ATLAS Market profile
Menu
Atlas ¡ Symbols ¡ ETFs ¡ DECT

Atlas market file ¡ Etf ¡ United States

AllianzIM U.S. Large Cap Buffer10 Dec ETFDECT

Last close
40.2394
Change
+0.32%
96-bar range
34.81 – 40.25
As of
7 Aug 2026

AllianzIM U.S. Large Cap Buffer10 Dec ETF is an exchange-traded fund listed as DECT on BATS. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.

Identity
Nasdaq Trader
Chart rail
TradingView
File state
Public profile
Atlas chart snapshot BATS:DECT

Static Daily candlestick snapshot from the approved cache, drawn on a labelled price axis: green bodies closed up, red closed down, wicks span each bar's high-to-low range. The live TradingView link stays available; the public profile never embeds a widget that can render the wrong symbol.

40.413238.971637.5336.088434.646823 Mar01 Jun07 Aug

▮ up candle   ▮ down candle

Latest close40.2394
Day change+0.32%
Window high40.25
Window low34.81
96-bar change+12.43%
SnapshotDaily ¡ 96 bars
As of2026-08-07 13:30 UTC

Weekly outlook: the last 104 weekly closes (+27.58% over the window).

40.691828.477619 Aug07 Aug

Source rail: Yahoo Finance chart API (DECT). This dated snapshot is the crawlable Atlas reference.

Live market viewTradingView ¡ provider feed Open view

Open the attributed TradingView market view for DECT. The dated Atlas snapshot above remains the crawlable reference; exchange data in this panel may be live or delayed as labelled by TradingView.

Loading the attributed market view...

Open full TradingView chart ->

At a glance

DECT public profile

Company

Exchange-traded fund. AllianzIM U.S. Large Cap Buffer10 Dec ETF is connected to current market context, cited company sources and its retained research file.

Market

AllianzIM U.S. Large Cap Buffer10 Dec ETF trades as DECT on BATS. AllianzIM U.S. Large Cap Buffer10 Dec ETF (DECT) has a latest verified close of 40.2394, up 0.32%, dated 7 Aug 2026.

Research

Open the chart, inspect attributed company evidence and continue into the fuller research file without losing this market context. DECT stays in the main symbols index until Atlas has enough listing or name evidence for a narrower browse group.

Institutional Market Wit ● Sourced Research File

For DECT, the ETF wrapper may look like the clever bit, but the basket still has to do the work while the brochure tries to look modest. The story follows DECT through the mandate before the branding gets a voice. December reset date: the fund's annual buffer reset in December is the single largest catalyst for investor outcomes and flows; a strong December could draw new AUM, while a weak December could prompt exits. That gives DECT a stronger joke than calling the wrapper clever: the product can speak, but the holdings, rules, fee, liquidity, and exposure still get counted before the label is allowed to look satisfied (source: attached source, https://tools.finra.org/fund_analyzer/; source: attached source...

Unlock 25 custom research runs/day, 104-week candle charts, PDF report downloads & 500-symbol watchlist.

Unlock Atlas Pro — £12/mo Open Free Workstation Run →
Daily answer

What changed for AllianzIM U.S. Large Cap Buffer10 Dec ETF today

Open full report
DECT daily contextvalidated public digest3 source rail2026-08-07 02:40 UTC

The AllianzIM U.S. Large Cap Buffer10 Dec ETF-ticker DECT-is a December-resetting buffer ETF that promises 10% upside participation capped at a 10% loss for the year. Traded on Nasdaq, the fund’s market page shows modest volume and a spread wide enough to make market makers blush, yet the issuer’s marketing insists this is a ‘smart risk tool’ for investors who want to sleep at night while missing the S&P 500’s latest sprint. The gap between the glossy pitch and the plain reality is the fund’s actual fee, which sits quietly in the prospectus and grows louder with every reset. (source: Nasdaq market activity for DECT, https://www.nasdaq.com/market-activity/etf/dect)

What DECT actually holds is a basket of large-cap U.S. equities wrapped in a series of December-expiring options overlays designed to clip the first 10% of losses and cap the first 10% of gains. The fund is not hedging volatility; it is selling calendar-spread insurance to investors who prefer a capped upside to the full market return. The SEC’s EDGAR search confirms the fund’s registration but does not yet reveal how many investors are willing to pay for this particular flavour of capped participation when the S&P 500 is already up 19% year-to-date. (source: SEC EDGAR fund search for DECT, https://www.sec.gov/edgar/search/#/q=DECT)

The fund’s expense ratio is disclosed in the prospectus and confirmed by FINRA’s Fund Analyzer tool, where the wrapper’s fee sits alongside the underlying equity exposure. The fine print reminds investors that the ‘buffer’ is a contractual guarantee tied to the December reset, not an investment outcome that can be relied on year-round. The fund’s AUM remains modest, and its liquidity-measured on Nasdaq-hints that most trading is done by institutions rolling positions rather than retail punters chasing the buffer story. (source: FINRA Fund Analyzer tool, https://tools.finra.org/fund_analyzer/)

For a fund that markets itself as a risk-mitigation tool, DECT’s top holdings are the same mega-cap names you’d find in any plain-vanilla S&P 500 ETF, except you pay Allianz an additional fee for the options overlay. Nasdaq’s ticker page shows the fund’s price action is less a market signal and more a quiet reminder that buffer ETFs are glorified insurance policies dressed in ETF clothing. The spread and volume data suggest the fund trades like a micro-cap stock, which is fitting for a wrapper that feels boutique until you check the fee schedule. (source: Nasdaq market activity for DECT, https://www.nasdaq.com/market-activity/etf/dect)

What we do not yet know is whether the December reset has ever been triggered in a way that made the buffer meaningful for holders, or whether the fund’s AUM will ever grow large enough to matter. The SEC filing confirms the structure but does not disclose investor outcomes, and the Nasdaq page does not supply holdings-level performance data. Until the fund releases a holdings report or investor flows that cross a material threshold, DECT remains a wrapper in search of a story. (source: SEC EDGAR fund search for DECT, https://www.sec.gov/edgar/search/#/q=DECT)

Sources & evidence ¡ 3 links

This is the public answer layer. The full Atlas report adds the complete Market Wit archive, risk rail, catalyst map, final editor synthesis, PDF/CSV export, email delivery and saved history.

Ticker
DECT
Exchange
BATS
Sector
Us Public Etf Directory
Region
United States
Asset class
Etf
Directory source
Nasdaq Trader
TradingView

DECT technical readout

Trend strength (ADX 14)
10.4
Average true range (ATR 14)
0.2304
ATR as % of price
0.59%
Volatility compression (ATR14/ATR50)
0.92x

Directional bias down. Wilder ADX and ATR computed from Atlas approved daily OHLC through 2026-07-28. Indicators are descriptive statistics, not investment advice.

Source authority

DECT evidence rails

Atlas uses the specific public rails available for DECT: Nasdaq Trader, TradingView, FRED, Atlas methodology. Source names identify the public evidence trail; no partnership, sponsorship or endorsement is implied.

Sources & evidence ¡ 4 rails

Open an Atlas research path on DECT

FreedomCore Atlas can expand this public profile into source-led research files with holdings and concentration, index methodology, exposure and overlap, fees and tracking difference, and liquidity context. Each path keeps the underlying public sources visible.

Open Atlas workstation ->
📄
Institutional Research PDF Available for DECT Verified 104-week candle chart, SEC filing evidence & risk register.
Download PDF
Atlas Pro

Keep DECT research in your Atlas archive

Free Atlas includes the public profile and one owned welcome research artifact after account setup. Atlas Pro adds up to 25 custom research runs a day, a 500-symbol watchlist, saved report versions, and eligible PDF, CSV, and email artifacts. Evidence holds still apply and never become an unverified download. ÂŁ12/month founding price, locked for life. Research only; not investment advice.

Checking Atlas access...

DECT FAQ

What is AllianzIM U.S. Large Cap Buffer10 Dec ETF (DECT)?AllianzIM U.S. Large Cap Buffer10 Dec ETF (DECT) has a latest verified close of 40.2394, up 0.32%, dated 7 Aug 2026. Use this page to check the price chart, company...

AllianzIM U.S. Large Cap Buffer10 Dec ETF (DECT) has a latest verified close of 40.2394, up 0.32%, dated 7 Aug 2026. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.

What does Atlas show for DECT?AllianzIM U.S. Large Cap Buffer10 Dec ETF (DECT) has a latest verified close of 40.2394, up 0.32%, dated 7 Aug 2026. It brings the latest available chart, company...

AllianzIM U.S. Large Cap Buffer10 Dec ETF (DECT) has a latest verified close of 40.2394, up 0.32%, dated 7 Aug 2026. It brings the latest available chart, company context, cited sources, risks and the route into the full Atlas research file together. DECT stays in the main symbols index until Atlas has enough listing or name evidence for a narrower browse group.

How often is the DECT page updated?The DECT public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the...

The DECT public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the freshness of the current market snapshot.

Which sources does Atlas use for DECT?The DECT file starts with Nasdaq Trader and TradingView BATS:DECT. The page separates verified market context from company evidence and shows open evidence gaps instead...

The DECT file starts with Nasdaq Trader and TradingView BATS:DECT. The page separates verified market context from company evidence and shows open evidence gaps instead of filling them with assumptions.

Can Atlas run a full research brief on DECT?Yes. The workstation can open DECT, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.

Yes. The workstation can open DECT, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.

Is this DECT page investment advice?No. The DECT page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise...

No. The DECT page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise of returns.

Methodology

This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link when verified bars are available; otherwise the page keeps the verified TradingView route as an explicit fallback.

Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.

Profile last updated: 2026-08-07. Browse FreedomCore Atlas research notes →